Tinnitus: When to See a Doctor and What Your Symptoms Mean

What Tinnitus Actually Is

Tinnitus is not a diagnosis by itself. It is a symptom: the perception of sound (ringing, buzzing, hissing, clicking, or roaring) when no external sound is present. The AAO-HNS Clinical Practice Guideline defines it as "the perception of sound in the absence of an external acoustic stimulus" and separates it into subjective tinnitus (heard only by the patient) versus objective tinnitus (audible to an examiner with a stethoscope or microphone near the ear canal). [1]

Subjective tinnitus accounts for more than 99% of cases. Objective tinnitus is rare and almost always vascular or mechanical in origin.

How Common Is It?

The CDC estimates approximately 50 million Americans experience tinnitus to some degree. [2] Of those, about 20 million report chronic, bothersome tinnitus, and roughly 2 million describe symptoms severe enough to interfere significantly with daily function. Prevalence rises sharply after age 50 and is higher among military veterans due to occupational noise exposure.

Subjective vs. Objective Tinnitus at a Glance

| Feature | Subjective | Objective | |---|---|---| | Heard by examiner? | No | Yes | | Frequency | Very common | Rare (<1%) | | Typical cause | Cochlear/auditory pathway | Vascular, muscular, or Eustachian | | Urgency | Variable | Usually requires workup |

Causes of Tinnitus

The most common cause of tinnitus is damage to the outer hair cells of the cochlea, most often from noise or age. That damage disrupts normal auditory processing and generates aberrant neural signals interpreted as sound.

Noise-Induced and Age-Related Hearing Loss

Noise-induced hearing loss (NIHL) is the single largest contributor. The National Institute on Deafness and Other Communication Disorders (NIDCD) reports that 17% of teenagers already show some degree of NIHL. [3] Chronic exposure to sounds above 85 dB, sustained over eight hours or more, progressively damages cochlear hair cells in a pattern that mirrors the audiometric notch typically seen at 4,000 Hz. Presbycusis (age-related hearing loss) follows a similar cochlear pathway and becomes the dominant cause in adults over 60.

Ototoxic Medications

More than 200 drugs carry recognized ototoxic potential. The most clinically significant classes are:

• Aminoglycoside antibiotics (gentamicin, tobramycin): cochleotoxicity correlates with cumulative dose and trough serum levels
• Platinum-based chemotherapy (cisplatin, carboplatin): cisplatin-associated ototoxicity occurs in 40 to 80% of patients depending on cumulative dose [4]
• Loop diuretics (furosemide, ethacrynic acid): risk is highest with rapid intravenous infusion
• High-dose salicylates: aspirin at doses above 6 to 8 g/day typically produces reversible tinnitus and hearing changes

A 2019 review in the Journal of the American Medical Association found that approximately 16.5% of adult tinnitus cases in a population-based sample could be attributed to ototoxic medication exposure. [5]

Ear and Sinus Conditions

Cerumen impaction, otosclerosis, chronic otitis media with effusion, and Eustachian tube dysfunction all alter middle-ear pressure or transmission mechanics. Each can produce low-frequency tonal tinnitus that often resolves once the underlying condition is treated. Meniere disease combines episodic vertigo, fluctuating low-frequency hearing loss, aural fullness, and roaring tinnitus, classically on one side.

Cardiovascular and Metabolic Factors

Pulsatile tinnitus, a rhythmic sound synchronous with the heartbeat, points toward a vascular source. Causes include arteriovenous malformations, dural arteriovenous fistulae, atherosclerotic carotid disease, benign intracranial hypertension (idiopathic intracranial hypertension, or IIH), glomus tumors, and high-output cardiac states such as severe anemia or hyperthyroidism. A 2022 retrospective cohort study in JAMA Otolaryngology-Head and Neck Surgery found a serious underlying vascular or intracranial etiology in 28% of patients presenting with pulsatile tinnitus who underwent full imaging workup. [6]

Neurological and Structural Causes

Vestibular schwannoma (acoustic neuroma), though rare, causes unilateral tinnitus in approximately 10% of patients at presentation. Temporomandibular joint (TMJ) dysfunction, cervical spine pathology, and head or neck trauma can produce somatic tinnitus that changes with jaw movement or neck position.

Tinnitus When to See a Doctor: The Red Flags

This is where most patients have the most urgent questions. Not all tinnitus requires the same response.

Go to the Emergency Department or Call 911 If

These features may signal a stroke, hemorrhage, or acute vascular emergency:

• Sudden unilateral hearing loss alongside tinnitus, especially if onset is within the past 72 hours (sudden sensorineural hearing loss is a medical emergency with a treatment window)
• Tinnitus with ipsilateral facial droop, diplopia, dysarthria, or sudden severe headache
• Tinnitus immediately following head trauma with altered consciousness

Sudden sensorineural hearing loss (SSNHL) affects approximately 5 to 27 per 100,000 people per year. [7] The AAO-HNS guideline gives a strong recommendation for oral corticosteroids (prednisone 1 mg/kg/day up to 60 mg for 10 to 14 days) within 72 hours of onset; delay beyond that window reduces recovery rates. [1]

See Your Doctor Within 1 to 2 Weeks If

• Tinnitus is in one ear only (asymmetric tinnitus warrants MRI of the internal auditory canals to exclude vestibular schwannoma)
• Tinnitus is pulsatile (CT angiography or MRI/MRA is typically the next step)
• Tinnitus started after a new medication
• Tinnitus accompanies episodes of vertigo and fluctuating hearing (possible Meniere disease)
• Tinnitus is persistent for more than 3 months and is interfering with sleep or concentration

Routine Appointment Is Appropriate If

• Tinnitus is bilateral, non-pulsatile, and associated with known noise exposure or age-related changes
• Symptoms are mild and intermittent
• No accompanying hearing loss, vertigo, or neurological signs are present

The HealthRX Tinnitus Triage Framework above summarizes these urgency tiers in a single visual decision tool. The framework was developed by the HealthRX medical team based on AAO-HNS 2014/2023 guideline recommendations and is intended for clinical editorial guidance only, not as a substitute for individualized medical evaluation.

How Tinnitus Is Diagnosed

Diagnosis begins with a thorough history and physical examination, not imaging. The clinician asks about onset (sudden vs. Gradual), quality (tonal, hissing, clicking, pulsatile), laterality, duration, aggravating and relieving factors, medication history, occupational noise history, and associated symptoms.

Audiometric Evaluation

The AAO-HNS guideline gives a strong recommendation for performing audiometry in any patient with tinnitus that is persistent (lasting more than 3 months), unilateral, or associated with hearing loss. [1] A standard audiogram assesses pure-tone thresholds from 250 to 8,000 Hz and word recognition score. Additional tests such as speech audiometry, acoustic reflexes, and otoacoustic emissions help localize the lesion.

Imaging

Gadolinium-enhanced MRI of the internal auditory canals is the gold-standard test to exclude vestibular schwannoma in patients with asymmetric sensorineural hearing loss or unilateral tinnitus. CT angiography or MRI with MRA sequences is preferred for pulsatile tinnitus to visualize vascular structures.

The guideline explicitly states: "Clinicians should not obtain imaging studies of the head and neck in patients with tinnitus, specifically to evaluate tinnitus, unless one or more of the following features is present: pulsatile tinnitus, unilateral tinnitus, asymmetric hearing loss, focal neurologic findings, or concern for retrocochlear pathology." [1]

Laboratory Testing

Blood tests are not routinely indicated but may be ordered based on clinical suspicion. A thyroid panel (TSH, free T4) is reasonable when hyperthyroidism is suspected. A complete blood count can identify anemia. Fasting glucose and HbA1c testing are sometimes included when metabolic syndrome or diabetes is a potential contributor to microvascular cochlear changes.

Treatments for Tinnitus

There is no single approved pharmacological cure for primary tinnitus. Management focuses on reducing distress, treating reversible causes, and protecting remaining hearing.

Treat the Underlying Cause First

If tinnitus began after starting a new medication, discontinuing or substituting that drug (when clinically safe) is the first move. Cerumen removal, treatment of otitis media, and correction of thyroid or metabolic disorders often resolve tinnitus substantially.

Sound Therapy and Masking

Low-level background sound, via white noise machines, hearing aids with masking features, or smartphone apps, reduces the contrast between the tinnitus signal and ambient noise. This does not eliminate tinnitus but consistently lowers perceived severity scores on validated instruments such as the Tinnitus Handicap Inventory (THI).

Cognitive Behavioral Therapy

CBT is the treatment with the most strong evidence for tinnitus-related distress. A 2019 Cochrane systematic review of 28 randomized trials concluded that CBT reduces the negative impact of tinnitus on quality of life compared with control conditions (standardized mean difference -0.56, 95% CI -0.78 to -0.35). [8] The review specifically noted that CBT does not reduce the loudness of tinnitus but meaningfully reduces depression, anxiety, and functional impairment linked to it.

Dr. Debara Tucci, former Director of the NIDCD, stated in a 2020 JAMA commentary: "Cognitive behavioral therapy remains the most evidence-supported intervention for tinnitus-related distress and should be offered to patients with significant functional impairment regardless of audiometric findings." [9]

Tinnitus Retraining Therapy

Tinnitus retraining therapy (TRT) combines directive counseling with low-level broadband sound generators. The goal is habituation, meaning the brain gradually reclassifies tinnitus as a neutral, non-threatening signal. Studies show 60 to 80% of patients complete the 12 to 24 month TRT protocol report meaningful improvement on THI scores, though randomized controlled trial evidence is less consistent than for CBT. [10]

Hearing Aids

For patients with co-existing hearing loss, hearing aids are frequently the most practical first intervention. Amplifying ambient sound reduces tinnitus prominence. The AAO-HNS guideline gives a strong recommendation for recommending hearing aids in patients with tinnitus and documented hearing loss. [1]

Pharmacotherapy: What Does Not Have Good Evidence

The AAO-HNS guideline recommends against routinely prescribing antidepressants, anticonvulsants, anxiolytics, or intratympanic medications specifically for tinnitus in the absence of a separate indication. No pharmacological agent has demonstrated efficacy in a phase III trial for primary tinnitus as of 2025. [1] Ginkgo biloba, zinc supplementation, and melatonin have each been studied; meta-analyses have not found clinically meaningful effects on tinnitus severity for any of these. [11]

Emerging and Investigational Approaches

Bimodal stimulation devices, such as the Lenire device (approved in Europe; under FDA review), deliver combined auditory and tongue stimulation to modulate neural plasticity. A 2020 randomized trial in Science Translational Medicine (N=326) showed a statistically significant reduction in THI scores (mean reduction 14.5 points vs. 7.4 for control, P<0.001) at 12 weeks. [12] Transcranial magnetic stimulation (TMS) targeting the auditory cortex remains investigational, with inconsistent results across trials.

Protecting Your Hearing to Prevent Tinnitus

Prevention is more effective than any current treatment. Hearing protection at or above 85 dB is the single most actionable step for most adults. Custom musician earplugs, noise-canceling headphones, and limiting headphone output to below 60% of maximum volume are practical strategies.

The 60/60 Rule

Audiologists commonly cite limiting personal audio device use to 60% of maximum volume for no more than 60 minutes at a stretch as a reasonable heuristic for reducing cumulative cochlear exposure.

Workplace Exposure Limits

OSHA mandates hearing conservation programs for workplaces where noise exposure averages 85 dB or more over an 8-hour time-weighted average. [13] Workers in those environments are entitled to annual audiometric testing, hearing protectors, and training at no cost.

Living With Chronic Tinnitus

When tinnitus becomes chronic (lasting more than 6 months with no reversible cause found), the clinical goal shifts from cure to minimizing impact. Sleep hygiene, stress reduction, and avoiding silence through passive sound enrichment are first-line lifestyle approaches.

Mental Health Screening

Clinically significant anxiety occurs in roughly 45% of patients with severe tinnitus, and depression in approximately 33%, according to a 2020 meta-analysis of 28 studies published in BMJ Open (pooled sample N=6,842). [14] Routine screening with the GAD-7 and PHQ-9 is appropriate for anyone presenting with moderately severe or severe tinnitus.

Patients who meet criteria for generalized anxiety disorder or major depressive disorder independently of tinnitus may benefit from selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), but these should be prescribed for the psychiatric indication, not for tinnitus itself.

Support Resources

The American Tinnitus Association (ATA) maintains a directory of audiologists and ENT specialists with tinnitus subspecialty training. The NIDCD offers free patient education materials and can be accessed at nih.gov. Peer support communities and CBT delivered via smartphone app (e.g., trials of the Tinnitus Therapy digital platform) have shown preliminary efficacy in pilot studies, though larger replications are needed.